Paragon Care Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PGC.AX research report →
Price Chart
About the company
Paragon Care Limited distributes medical equipment, devices, and consumable products in Australia, New Zealand, and Asia. The company designs, manufactures, and distributes reagent red blood cells, monoclonal blood grouping reagents, and ancillary products for immunohematology laboratories; offers ophthalmology and optometry, neonatal vision screening solutions, and procedural kits. It also provides neonatal and paediatric assessment, including newborn hearing and vision screening, jaundice management, NICU video monitoring, brain monitoring, breast milk tracking, electrodes; sterilisable transducers designed for surgical procedures, digital theatre integration, infection control, infusion therapy, temperature management, enteral feeding, pain management, lasers, operating room products, surgical consumables, and ultrasound systems.
- CEO
- Carmen Riley
- IPO
- 1999
- Employees
- 869
- HQ
- Mount Waverley, VIC, AU
Get TickerSpark's AI analysis on PGC.AX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $231.74M
- P/E
- -16.67
- Fwd P/E
- 8.94
- PEG
- 0.12
- P/S
- 0.06
- P/B
- 0.76
- EV/EBITDA
- 16.21
- Div Yield
- 0.00%
- Gross Margin
- 6.63%
- Op Margin
- 0.65%
- Net Margin
- -0.38%
- ROE
- -4.47%
- ROIC
- 2.03%
Latest fiscal year · YoY change
- Revenue
- $3.61B+21.7%
- Gross Profit
- $324.00M+84.0%
- Op Income
- $89.53M
- Net Income
- $20.57M+145.5%
- EPS
- $0.01+37.8%
- OCF Growth
- -125.5%
- FCF Growth
- -191.7%
- 52W High
- $0.40
- 52W Low
- $0.13
- 50D MA
- $0.14
- 200D MA
- $0.19
- Beta
- -0.30
- RSI (14)
- 59
- Avg Volume
- 631.85K
No earnings-call transcripts are available for PGC.AX yet.
- Free Float
- 30.3%
- Shares Outstanding
- 1.66B
- Float Shares
- 501.54M
Held by 1 ETFs
Biggest fund positions in PGC.AX by dollar value.
Our PGC.AX coverage
Recent articles, reports, and earnings notes.
No research on PGC.AX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PGC.AX report →